Targeting of DNMT3B in the plasma cell cancer multiple myeloma disturbs cancer cell growth and clonogenicity and boosts the anti-tumor activity of the proteasome inhibitor bortezomib.

Catharina Muylaert, Lien Ann Van Hemelrijck, Philip Vlummens, Anke Maes, Kim De Veirman, Eline Menu, Karin Vanderkerken, Elke De Bruyne

Onderzoeksoutput: Poster

Vingerafdruk

Duik in de onderzoeksthema's van 'Targeting of DNMT3B in the plasma cell cancer multiple myeloma disturbs cancer cell growth and clonogenicity and boosts the anti-tumor activity of the proteasome inhibitor bortezomib.'. Samen vormen ze een unieke vingerafdruk.

Medicine & Life Sciences